Citation Impact
Citing Papers
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
2010 StandoutScience
Development of a leishmaniasis vaccine: the importance of MPL
2003
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018 Standout
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
IL-13 Is a Susceptibility Factor forLeishmania majorInfection
2000
Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation
2015 Standout
Evaluation of African medicinal plants for their in vitro trypanocidal activity
1996
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?
2004
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
1998
Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial
2008 Standout
Sleep, sleep deprivation and infectious disease: Studies in animals
1995
The immunology of susceptibility and resistance to Leishmania major in mice
2002 Standout
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
Human African Trypanosomiasis: Epidemiology and Control
2006
Protective immune mechanisms in helminth infection
2007 Standout
Human African trypanosomiasis
2009
Chemotherapy of human African trypanosomiasis: current and future prospects
2003
The epidemiology and control of human African trypanosomiasis
2001
Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas’ disease, and leishmaniasis
2007
Diagnostics for the developing world
2004 Standout
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Pentamidine uptake and resistance in pathogenic protozoa: past, present and future
2003
Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates
2013
Antibiotics LL-Z1272 identified as novel inhibitors discriminating bacterial and mitochondrial quinol oxidases
2008 StandoutNobel
Immunopathology of multiple sclerosis
2015 Standout
Neglected tropical diseases: survey and geometry of randomised evidence
2012
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next?
2008
Structural and Functional Significance of Cysteine Residues of Glutathione-independent Prostaglandin D Synthase
1995
Lay health workers in primary and community health care
2005
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Review: HIV infection and tropical parasitic diseases – deleterious interactions in both directions?
2002
Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates
2010 StandoutNobel
Update on Myocarditis
2012 Standout
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2003 Standout
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
2007 Standout
Heavy Metal Toxicity and the Environment
2012 Standout
Gut microbiota, metabolites and host immunity
2016 Standout
CTLA4 (CD152) modulates the Th subset response and alters the course of experimentalLeishmania major infection
1998
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Prostaglandin D2 and sleep regulation
1999
Polyamines and cancer: old molecules, new understanding
2004
Ghrelin: Structure and Function
2005 Standout
Sleep, Immunity, and Circadian Clocks: A Mechanistic Model
2010
In vitro antitrypanosomal activity of plant terpenes against Trypanosoma brucei
2011 StandoutNobel
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Control of Neglected Tropical Diseases
2007 Standout
Leishmania species: models of intracellular parasitism
1999
Leishmaniasis host response loci (lmr1–3) modify disease severity through a Th1/Th2-independent pathway
2003
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
2001 Standout
Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9
2002 StandoutNobel
Nitric oxide and the immune response
2001 Standout
Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
1999
Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis
2001
Control of Sleep and Wakefulness
2012
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Advances in leishmaniasis
2005 Standout
2000
Spermidine in health and disease
2018 StandoutScience
Plant Products as Antimicrobial Agents
1999 Standout
Design and optimization of enzymatic activity in a de novo β‐barrel scaffold
2022 StandoutNobel
CYCLOOXYGENASES 1 AND 2
1998 StandoutNobel
Association between the Tumor Necrosis Factor Locus and the Clinical Outcome ofLeishmania chagasiInfection
2002
About Sleep's Role in Memory
2013 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
The Illusion of Sustainability
2007 StandoutNobel
Enzymes of the Cyclooxygenase Pathways of Prostanoid Biosynthesis
2011
The wound repair response controls outcome to cutaneous leishmaniasis
2005
Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain.
1993
CTLA-4-Mediated Inhibition in Regulation of T Cell Responses: Mechanisms and Manipulation in Tumor Immunotherapy
2001 StandoutNobel
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
T-cell quality in memory and protection: implications for vaccine design
2008
Cardiac Involvement with Parasitic Infections
2010
Leishmaniasis: Current Status of Vaccine Development
2001
Prostaglandins and Inflammation
2011 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Differentiation of Effector CD4 T Cell Populations
2010 Standout
Drug Resistance in Leishmaniasis
2006 Standout
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Neuroendocrine Control of Growth Hormone Secretion
1999
Works of F. Doua being referenced
Evaluation du Testryp CATT appliqué au sang prélevé sur papier filtre et au sang dilué, dans le foyer de trypanosomiase à Trypanosoma brucei gambiense en Côte d'Ivoire.
1991
Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'Ivoire
1991
Human trypanosomiasis in the Ivory Coast: therapy and problems
1993
Sleep-Wake Cycle in Human African Trypanosomiasis
1993
IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test
2002
The pharmacokinetics of eflornithine (?-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness
2004
A comparison of parasitological methods for the diagnosis of gambian trypanosomiasis in an area of low endemicity in Côte d'Ivoire
1994
Relationship of Plasma Growth Hormone to Slow-Wave Sleep in African Sleeping Sickness
1996
Effectiveness of a 10‐Day Melarsoprol Schedule for the Treatment of Late‐Stage Human African Trypanosomiasis: Confirmation from a Multinational Study (Impamel II)
2005
The Efficacy of Pentamidine in the Treatment of Early-Late Stage Trypanosoma brucei gambiense Trypanosomiasis
1996
Human African trypanosomiasis: quantitative and qualitative assessment of intrathecal immune response
2003
Endotoxins in the blood and cerebrospinal fluid of patients with African sleeping sickness
1996
Pharmacokinetic Properties of the Trypanocidal Drug Melarsoprol
1993
The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients
1990
Human immunodeficiency virus infection and human African trypanosomiasis: a case-control study in Côte d'Ivoire
1995
Assessment of central nervous system involvement in gambiense trypanosomiasis: value of the cerebro‐spinal white cell count
1998
Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes
2000
Detection and characterization of autoantibodies directed against neurofilament proteins in human African trypanosomiasis.
1997
HUMAN AFRICAN TRYPANOSOMIASIS (T.b. GAMBIENSE): A STUDY OF 16 FATAL CASES OF SLEEPING SICKNESS WITH SOME OBSERVATIONS ON ACUTE REACTIVE ARSENICAL ENCEPHALOPATHY
1986
[Detecting sleeping sickness: comparative efficacy of mobile teams and community health workers].
1998
Detection and Characterization of Autoantibodies Directed against Neurofilament Proteins in Human African Trypanosomiasis
1997
[Evaluation of the parasitologic technics used in the diagnosis of human Trypanosoma gambiense trypanosomiasis in the Ivory Coast].
1994
Short-course eflornithine in Gambian trypanosomiasis: a multicentre randomized controlled trial.
2000